+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global CRISPR & Cas Genes Market by Component (Product, Service), Application (Agricultural, Biomedical), End-user - Forecast 2024-2030

  • PDF Icon

    Report

  • 199 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5336284
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The CRISPR & Cas Genes Market size was estimated at USD 3.81 billion in 2023, USD 5.04 billion in 2024, and is expected to grow at a CAGR of 32.40% to reach USD 27.21 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the CRISPR & Cas Genes Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the CRISPR & Cas Genes Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the CRISPR & Cas Genes Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca plc, Beam Therapeutics Inc., Beckman Coulter, Inc., Calyxt, Inc., Caribou Biosciences, Inc., CRISPR Therapeutics AG, Danaher Corporation, Editas Medicine, Inc., Hera Biolabs, Horizon Discovery Group Plc, Inscripta, Inc., Integrated Dna Technologies, Inc., Intellia Therapeutics, Inc., Lonza Group, and Mammoth Biosciences.

Market Segmentation & Coverage

This research report categorizes the CRISPR & Cas Genes Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Component
    • Product
      • Antibodies
      • Design Tool
      • Kits & Enzymes
        • DNA-Free Cas
        • Vector-Based Cas
      • Libraries
    • Service
      • Cell Line Engineering
      • DNA Synthesis
      • gRNA Design
      • Microbial Gene Editing
  • Application
    • Agricultural
    • Biomedical
      • Disease Model Studies
      • Epigenetics
      • Functional Genomics
      • Genome Engineering
  • End-user
    • Academics & Government Research Institutes
    • Biotechnology & Pharmaceutical Companies
    • Contract Research Organizations
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the CRISPR & Cas Genes Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the CRISPR & Cas Genes Market?
  3. What are the technology trends and regulatory frameworks in the CRISPR & Cas Genes Market?
  4. What is the market share of the leading vendors in the CRISPR & Cas Genes Market?
  5. Which modes and strategic moves are suitable for entering the CRISPR & Cas Genes Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. CRISPR & Cas Genes Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Development of CRISPR-based diagnostic assays for sample tissue screening
5.1.1.2. High prevalence of genetic disorders
5.1.1.3. Rising application in drug discovery, biomedical research, and non-transgenic bleeding
5.1.2. Restraints
5.1.2.1. Off-target effects of CRISPR technology
5.1.3. Opportunities
5.1.3.1. Evolution of anti-CRISPR protein
5.1.3.2. Research and development for novel application of CRISPR-Cas genes
5.1.4. Challenges
5.1.4.1. Patent landscape and dispute
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. CRISPR & Cas Genes Market, by Component
6.1. Introduction
6.2. Product
6.3.1. Antibodies
6.3.2. Design Tool
6.3.3. Kits & Enzymes
6.3.4.1. DNA-Free Cas
6.3.4.2. Vector-Based Cas
6.3.4. Libraries
6.3. Service
6.4.1. Cell Line Engineering
6.4.2. DNA Synthesis
6.4.3. gRNA Design
6.4.4. Microbial Gene Editing
7. CRISPR & Cas Genes Market, by Application
7.1. Introduction
7.2. Agricultural
7.3. Biomedical
7.4.1. Disease Model Studies
7.4.2. Epigenetics
7.4.3. Functional Genomics
7.4.4. Genome Engineering
8. CRISPR & Cas Genes Market, by End-user
8.1. Introduction
8.2. Academics & Government Research Institutes
8.3. Biotechnology & Pharmaceutical Companies
8.4. Contract Research Organizations
9. Americas CRISPR & Cas Genes Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific CRISPR & Cas Genes Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa CRISPR & Cas Genes Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. AstraZeneca plc
13.1.2. Beam Therapeutics Inc.
13.1.3. Beckman Coulter, Inc.
13.1.4. Calyxt, Inc.
13.1.5. Caribou Biosciences, Inc.
13.1.6. CRISPR Therapeutics AG
13.1.7. Danaher Corporation
13.1.8. Editas Medicine, Inc.
13.1.9. Hera Biolabs
13.1.10. Horizon Discovery Group Plc
13.1.11. Inscripta, Inc.
13.1.12. Integrated Dna Technologies, Inc.
13.1.13. Intellia Therapeutics, Inc.
13.1.14. Lonza Group
13.1.15. Mammoth Biosciences
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. CRISPR & CAS GENES MARKET RESEARCH PROCESS
FIGURE 2. CRISPR & CAS GENES MARKET SIZE, 2023 VS 2030
FIGURE 3. CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CRISPR & CAS GENES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CRISPR & CAS GENES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CRISPR & CAS GENES MARKET DYNAMICS
FIGURE 7. CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
FIGURE 8. CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. CRISPR & CAS GENES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. CRISPR & CAS GENES MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. CRISPR & CAS GENES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 6. CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. CRISPR & CAS GENES MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CRISPR & CAS GENES MARKET SIZE, BY DESIGN TOOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 12. CRISPR & CAS GENES MARKET SIZE, BY DNA-FREE CAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. CRISPR & CAS GENES MARKET SIZE, BY VECTOR-BASED CAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. CRISPR & CAS GENES MARKET SIZE, BY LIBRARIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. CRISPR & CAS GENES MARKET SIZE, BY SERVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 17. CRISPR & CAS GENES MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. CRISPR & CAS GENES MARKET SIZE, BY DNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. CRISPR & CAS GENES MARKET SIZE, BY GRNA DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. CRISPR & CAS GENES MARKET SIZE, BY MICROBIAL GENE EDITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. CRISPR & CAS GENES MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 25. CRISPR & CAS GENES MARKET SIZE, BY DISEASE MODEL STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. CRISPR & CAS GENES MARKET SIZE, BY EPIGENETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. CRISPR & CAS GENES MARKET SIZE, BY FUNCTIONAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. CRISPR & CAS GENES MARKET SIZE, BY GENOME ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. CRISPR & CAS GENES MARKET SIZE, BY ACADEMICS & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. CRISPR & CAS GENES MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. CRISPR & CAS GENES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. CANADA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 56. CANADA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. CANADA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 58. CANADA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 59. CANADA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. CANADA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 61. CANADA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. MEXICO CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 63. MEXICO CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. MEXICO CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 65. MEXICO CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 66. MEXICO CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. MEXICO CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 68. MEXICO CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 85. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 86. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. CHINA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 93. CHINA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. CHINA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 95. CHINA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 96. CHINA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. CHINA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 98. CHINA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. INDIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 100. INDIA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. INDIA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 102. INDIA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 103. INDIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. INDIA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 105. INDIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 107. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. JAPAN CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 114. JAPAN CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. JAPAN CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 116. JAPAN CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 117. JAPAN CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. JAPAN CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 119. JAPAN CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 121. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 128. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 130. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 135. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 137. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 142. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 144. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 149. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 151. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. THAILAND CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 156. THAILAND CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 157. THAILAND CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 158. THAILAND CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 159. THAILAND CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. THAILAND CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 161. THAILAND CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 163. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 165. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 177. DENMARK CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 178. DENMARK CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. DENMARK CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 180. DENMARK CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 181. DENMARK CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. DENMARK CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 183. DENMARK CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. EGYPT CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 185. EGYPT CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. EGYPT CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 187. EGYPT CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 188. EGYPT CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. EGYPT CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 190. EGYPT CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. FINLAND CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 192. FINLAND CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. FINLAND CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 194. FINLAND CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 195. FINLAND CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. FINLAND CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 197. FINLAND CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 198. FRANCE CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 199. FRANCE CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 200. FRANCE CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 201. FRANCE CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 202. FRANCE CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. FRANCE CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 204. FRANCE CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 205. GERMANY CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 206. GERMANY CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 207. GERMANY CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 208. GERMANY CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 209. GERMANY CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. GERMANY CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 211. GERMANY CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 219. ITALY CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 220. ITALY CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 221. ITALY CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 222. ITALY CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 223. ITALY CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. ITALY CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 225. ITALY CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 227. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 233. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 240. NORWAY CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 241. NORWAY CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 242. NORWAY CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 243. NORWAY CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 244. NORWAY CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. NORWAY CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 246. NORWAY CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 247. POLAND CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 248. POLAND CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 249. POLAND CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 250. POLAND CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 251. POLAND CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. POLAND CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 253. POLAND CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 254. QATAR CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 255. QATAR CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 256. QATAR CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 257. QATAR CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 258. QATAR CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. QATAR CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 260. QATAR CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 268. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 276. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 282. SPAIN CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 283. SPAIN CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 284. SPAIN CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 285. SPAIN CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 286. SPAIN CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. SPAIN CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 288. SPAIN CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 289. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 290. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 291. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 297. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 303. TURKEY CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 304. TURKEY CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 305. TURKEY CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 306. TURKEY CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 307. TURKEY CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 308. TURKEY CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 309. TURKEY CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 317. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 318. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 319. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 320. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 322. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 324. CRISPR & CAS GENES MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 325. CRISPR & CAS GENES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 326. CRISPR & CAS GENES MARKET LICENSE & PRICING

Companies Mentioned

  • AstraZeneca plc
  • Beam Therapeutics Inc.
  • Beckman Coulter, Inc.
  • Calyxt, Inc.
  • Caribou Biosciences, Inc.
  • CRISPR Therapeutics AG
  • Danaher Corporation
  • Editas Medicine, Inc.
  • Hera Biolabs
  • Horizon Discovery Group Plc
  • Inscripta, Inc.
  • Integrated Dna Technologies, Inc.
  • Intellia Therapeutics, Inc.
  • Lonza Group
  • Mammoth Biosciences

Methodology

Loading
LOADING...

Table Information